Norethisterone with mestranol
Brand names: Norinyl-1
This is a fixed-dose combined oral contraceptive pairing the progestogen norethisterone with the oestrogen mestranol, used for contraception and cycle control.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Mestranol (a prodrug converted to ethinylestradiol) and norethisterone together suppress gonadotrophin release to inhibit ovulation, while also thickening cervical mucus and altering the endometrium.
Prescribing in practice
- As a combined oestrogen-containing preparation it raises the risk of venous and arterial thromboembolism and is contraindicated where this risk is high, such as migraine with aura, established cardiovascular disease, or smoking in older women.
- Efficacy may be reduced by enzyme-inducing drugs, and the woman should be assessed against UK Medical Eligibility Criteria before starting.
- Counsel on what to do about missed pills and that additional precautions may be needed in certain situations.
Monitoring
Check blood pressure and review thrombotic and cardiovascular risk factors before starting and periodically during use.
Counselling the patient
- Take it regularly and follow the missed-pill instructions to keep contraceptive cover.
- Stop and seek urgent care for severe leg pain or swelling, chest pain, breathlessness, or sudden severe headache or visual change.
- Tell your clinician about migraines with aura, smoking, and any new medicines.
Evidence & guidelines
Combined oral contraceptives are prescribed in line with the UK Medical Eligibility Criteria and Faculty of Sexual and Reproductive Healthcare guidance.
Reference: FSRH; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21